+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Blood Transfusion Diagnostics Market Research Report by Product Type (Instruments and Kits and Reagents), Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4989624
  • Report
  • April 2022
  • Region: Global
  • 195 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories.
  • Beckman Coulter, Inc.
  • Diagast
  • Fujirebio
  • Immucor
  • Novartis AG
The Global Blood Transfusion Diagnostics Market size was estimated at USD 2,931.02 million in 2021, USD 3,209.89 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.69% to reach USD 5,105.78 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Blood Transfusion Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Instruments and Kits and Reagents.
  • Based on Application, the market was studied across Blood Grouping and Disease Screening.
  • Based on End-User, the market was studied across Diagnostic Laboratories, Hospitals, and Plasma Fractionation Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Blood Transfusion Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Blood Transfusion Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Blood Transfusion Diagnostics Market, including Abbott Laboratories., BAG Health Care GmbH, Beckman Coulter, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biokit, BioMérieux, Diagast, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Fujirebio, Grifols, S.A., Hologic/Gen-Probe, Immucor, LabCorp, Merck KGaA, Novartis AG, Ortho Clinical Diagnostics, Quidel, Quotient Ltd., Sanofi Genzyme, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., UVA Medical Laboratories, and Versiti.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Blood Transfusion Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Blood Transfusion Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Blood Transfusion Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Blood Transfusion Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Blood Transfusion Diagnostics Market?
6. What is the market share of the leading vendors in the Global Blood Transfusion Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Blood Transfusion Diagnostics Market?
Frequently Asked Questions about the Global Blood Transfusion Diagnostics Market

What is the estimated value of the Global Blood Transfusion Diagnostics Market?

The Global Blood Transfusion Diagnostics Market was estimated to be valued at $2931.0 Million in 2021.

What is the growth rate of the Global Blood Transfusion Diagnostics Market?

The growth rate of the Global Blood Transfusion Diagnostics Market is 9.6%, with an estimated value of $5105.8 Million by 2027.

What is the forecasted size of the Global Blood Transfusion Diagnostics Market?

The Global Blood Transfusion Diagnostics Market is estimated to be worth $5105.8 Million by 2027.

Who are the key companies in the Global Blood Transfusion Diagnostics Market?

Key companies in the Global Blood Transfusion Diagnostics Market include Abbott Laboratories., BAG Health Care GmbH, Beckman Coulter, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio, Rad Laboratories, Inc., Biokit and Diagast.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories.
  • Beckman Coulter, Inc.
  • Diagast
  • Fujirebio
  • Immucor
  • Novartis AG

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of blood-related disorders such as hemophilia and cancer globally
5.1.1.2. Growing awareness campaigns with government support and demand for screened blood products
5.1.1.3. Rising cases of road accidents, trauma, and surgeries worldwide
5.1.2. Restraints
5.1.2.1. Dearth of infrastructure and skilled professional
5.1.3. Opportunities
5.1.3.1. Surge in availability of technologically advanced screening analyzers
5.1.3.2. Integration of approved instrument assays in laboratories and hospitals
5.1.4. Challenges
5.1.4.1. High operating cost and strict regulatory policies for approval
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Blood Transfusion Diagnostics Market, by Product Type
6.1. Introduction
6.2. Instruments and Kits
6.3. Reagents
7. Blood Transfusion Diagnostics Market, by Application
7.1. Introduction
7.2. Blood Grouping
7.3. Disease Screening
8. Blood Transfusion Diagnostics Market, by End-User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals
8.4. Plasma Fractionation Companies
9. Americas Blood Transfusion Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Blood Transfusion Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Blood Transfusion Diagnostics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories.
13.2. BAG Health Care GmbH
13.3. Beckman Coulter
13.4. Beckman Coulter, Inc.
13.5. Becton, Dickinson and Company
13.6. Bio-Rad Laboratories, Inc.
13.7. Biokit
13.8. BioMérieux
13.9. Diagast
13.10. DiaSorin S.p.A
13.11. F. Hoffmann-La Roche Ltd
13.12. Fujirebio
13.13. Grifols, S.A.
13.14. Hologic/Gen-Probe
13.15. Immucor
13.16. LabCorp
13.17. Merck KGaA
13.18. Novartis AG
13.19. Ortho Clinical Diagnostics
13.20. Quidel
13.21. Quotient Ltd.
13.22. Sanofi Genzyme
13.23. Siemens Healthcare Private Limited
13.24. Thermo Fisher Scientific Inc.
13.25. UVA Medical Laboratories
13.26. Versiti
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: DYNAMICS
FIGURE 2. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2027
FIGURE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 17. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2027
FIGURE 19. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. AUSTRALIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. INDONESIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. MALAYSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. PHILIPPINES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. SINGAPORE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. SOUTH KOREA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. TAIWAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. THAILAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. NETHERLANDS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. QATAR BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. SOUTH AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 56. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. AUSTRALIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. INDONESIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. MALAYSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. PHILIPPINES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. SINGAPORE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. SOUTH KOREA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. TAIWAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. THAILAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. NETHERLANDS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. QATAR BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. SOUTH AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: SCORES
TABLE 72. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 73. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 74. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: RANKING
TABLE 75. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 76. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 77. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 78. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 79. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 80. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 81. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories.
  • BAG Health Care GmbH
  • Beckman Coulter
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biokit
  • BioMérieux
  • Diagast
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche Ltd
  • Fujirebio
  • Grifols, S.A.
  • Hologic/Gen-Probe
  • Immucor
  • LabCorp
  • Merck KGaA
  • Novartis AG
  • Ortho Clinical Diagnostics
  • Quidel
  • Quotient Ltd.
  • Sanofi Genzyme
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
  • UVA Medical Laboratories
  • Versiti
Note: Product cover images may vary from those shown

Loading
LOADING...